サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Artificial Intelligence in Healthcare Market: World Market Analysis By Component (Hardware, Software, Services), Technology (Natural Language Processing, Machine Learning), End User, By Region, By Country (2019 Edition): Forecast to 2024 -- By End User (Healthcare Providers, Pharmaceutical Organizations, Others), By Region (North America, Europe, APAC, ROW), By Country (U.S, Canada, UK, Germany, China, India)

ヘルスケア市場における人工知能:コンポーネント別(ハードウェア、ソフトウェア、サービス)、技術別(自然言語処理、機械学習)、エンドユーザー、地域および国別分析(2019年度版)

レポート概要

本レポートは、広範なプライマリー調査(業界専門家、企業、出資者からの情報)やセカンダリー調査を通して作成され、コンポーネント別(ハードウェア、ソフトウェア、サービス)、技術別(自然言語処理、機械学習)、エンドユーザー別(医療提供者、製薬組織、その他)、地域別(北米、欧州、APAC、その他)、および国別(米国、カナダ、イギリス、ドイツ、中国、インド)の分析を元に、世界のヘルスケア市場における人工知能を調査しました。

ヘルスケア市場における人工知能は、2019~2024年にかけて、CAGR 50.78%で勢い良く成長する見込みです。

過去数年にわたって、一連の経済的、人口統計学的、技術的、そして環境的要因が、ヘルスケア業界におけるデジタル革命を刺激してきました。Google、IBM Watson、Intel Corporation、Microsoft Corporation、General Visionなどの主要企業によるヘルスケアにおけるAIに関連する研究開発プロジェクトへの投資の増加は、市場を正しい方向に押し上げてきました。本レポートでは、市場を人工知能技術、コンポーネントおよびエンドユーザーに基づいてセグメント化しています。コンポーネントの種類別では、ソフトウェアが世界市場を支配している一方で、人工知能サービス分野は注目に値する速度で成長を遂げてきました。地域別では、2018年に北米が世界のヘルスケア市場において最大の地域シェアを占めています。しかし予測期間中に、アジア太平洋地域は最高のペースで成長する見込みです。アジア太平洋地域の堅調な成長率を牽引している主因には、広大な消費者基盤の存在、医療インフラの大幅な改善などが挙げられます。

本レポートでは、ヘルスケア市場における人工知能と市場規模、シェアおよび成長要因に関する統計と情報を提供します。また、最先端の市場情報を提供し、意思決定者が適切な投資評価を行うのに役立ちます。さらに、主な市場促進要因、課題、ビジネスチャンス、様々な企業の市場参入戦略についても取り上げます。

■調査範囲

世界市場分析(実データ:2014~2018年、予測期間:2019~2024年)

  • ヘルスケア市場における人工知能‐規模、成長、予測
  • コンポーネント別(ハードウェア、ソフトウェア、サービス)
  • 技術別(自然言語処理、機械学習)
  • エンドユーザー別(医療提供者、製薬組織、その他)

地域市場分析‐北米、欧州、アジア太平洋、その他(実データ:2014~2018年、予測期間:2019~2024年)

  • ヘルスケア市場における人工知能‐規模、成長、予測
  • コンポーネント別(ハードウェア、ソフトウェア、サービス)
  • エンドユーザー別(医療提供者、製薬組織、その他)

国別分析‐米国、カナダ、イギリス、ドイツ、インド、中国(実データ:2014~2018年、予測期間:2019~2024年)

  • ヘルスケア市場における人工知能‐規模、成長、予測

その他

  • 市場ダイナミクス‐促進要因、抑制要因
  • 市場動向
  • SWOT分析
  • ポーターファイブフォース分析
  • 政策および規制展望
  • 市場勢力図
  • 企業分析‐IBM Watson Health, Stryker Corporation, General Vision, NVIDIA Corporation, CloudMedx Inc., Next IT Corp., DEEP Genomics, Microsoft Corporation, General Electric, Google.

レポート詳細

目次

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Artificial Intelligence in Healthcare Market Outlook

5. Global Artificial Intelligence in Healthcare Market: Growth and Forecas
5.1 By Value (2014-2018)
5.2 By Value (2019-2024)

6. Global Artificial Intelligence in Healthcare Market: Segmental Analysis
6.1 Global Artificial Intelligence in Healthcare Market, By Component:
6.1.1 Global AI Hardware in Healthcare Market, By Value (2014-2018)
6.1.2 Global AI Hardware in Healthcare Market, By Value (2019-2024)
6.1.3 Global AI Software in Healthcare Market, By Value (2014-2018)
6.1.4 Global AI Software in Healthcare Market, By Value (2019-2024)
6.1.5 Global AI Services in Healthcare Market, By Value (2014-2018)
6.1.6 Global AI Services in Healthcare Market, By Value (2019-2024)

6.2 Global Artificial Intelligence in Healthcare Market, By Technology:
6.2.1 Global Natural Language Processing in Healthcare Market, By Value (2014-2018)
6.2.2 Global Natural Language Processing in Healthcare Market, By Value (2019-2024)
6.2.3 Global Machine Learning in Healthcare Market, By Value (2014-2018)
6.2.4 Global Machine Learning in Healthcare Market, By Value (2019-2024)
6.2.5 Other AI Technologies in Healthcare Market, By Value (2014-2018)
6.2.6 Other AI Technologies in Healthcare Market, By Value (2019-2024)

6.3 Global Artificial Intelligence in Healthcare Market, By End User
6.3.1 Global Healthcare Providers in AI Market, By Value (2014-2018)
6.3.2 Global Healthcare Providers in AI Market, By Value (2019-2024)
6.3.3 Global Pharmaceutical Organizations in AI Market, By Value (2014-2019)
6.3.4 Global Pharmaceutical Organizations in AI Market, By Value (2019-2024)
6.3.5 Other Global End Users in Healthcare Market, By Value (2014-2018)
6.3.6 Other Global End Users in Healthcare Market, By Value (2019-2024)

7. Global Artificial Intelligence in Healthcare Market: Regional Analysis
7.1 Global Artificial Intelligence in Healthcare Market Size, By Region : Breakdown (%)
7.1.1 Global Artificial Intelligence in Healthcare Market Size, By Region, 2018 (%)
7.1.2 Global Artificial Intelligence in Healthcare Market Size, By Region, 2024F (%)

7.2 North America Artificial Intelligence in Healthcare Market: Growth and Forecast
7.2.1 By Value (2014-2018)
7.2.2 By Value (2019-2024)
7.2.3 By Component, By Value (2014-2018)
7.2.4 By Component, By Value (2019-2024)
7.2.5 By Technology, By Value (2014-2018)
7.2.6 By Technology, By Value (2019-2024)

7.3 North America Artificial Intelligence in Healthcare Market: Country Analysis (U.S and Canada)
7.3.1 U.S Artificial Intelligence in Healthcare Market, By Value (2014-2018)
7.3.2 U.S Artificial Intelligence in Healthcare Market, By Value (2019-2024)
7.3.3 Canada Artificial Intelligence in Healthcare Market, By Value (2014-2024)
7.3.4 Canada Artificial Intelligence in Healthcare Market, By Value (2014-2024)

7.4 Europe Artificial Intelligence in Healthcare Market: Growth and Forecast
7.4.1 By Value (2014-2018)
7.4.2 By Value (2019-2024)
7.4.3 By Component, By Value (2014-2018)
7.4.4 By Component, By Value (2019-2024)
7.4.5 By Technology, By Value (2014-2018)
7.4.6 By Technology, By Value (2019-2024)

7.5 Europe Artificial Intelligence in Healthcare Market: Country Analysis (Germany and U.K)
7.5.1 Germany Artificial Intelligence in Healthcare Market, By Value (2014-2018)
7.5.2 Germany Artificial Intelligence in Healthcare Market, By Value (2019-2024)
7.5.3 U.K Artificial Intelligence in Healthcare Market, By Value (2014-2018)
7.5.4 U.K Artificial Intelligence in Healthcare Market, By Value (2019-2024)

7.6 APAC Artificial Intelligence in Healthcare Market: Growth and Forecast
7.6.1 By Value (2014-2018)
7.6.2 By Value (2019-2024)
7.6.3 By Component, By Value (2014-2018)
7.6.4 By Component, By Value (2019-2024)
7.6.5 By Technology, By Value (2014-2018)
7.6.6 By Technology, By Value (2019-2024)

7.7 APAC Artificial Intelligence in Healthcare Market: Country Analysis (India and China)
7.7.1 India Artificial Intelligence in Healthcare Market, By Value (2014-2018)
7.7.2 India Artificial Intelligence in Healthcare Market, By Value (2019-2024)
7.7.3 China Artificial Intelligence in Healthcare Market, By Value (2014-2018)
7.7.4 China Artificial Intelligence in Healthcare Market, By Value (2019-2024)

7.8 ROW Artificial Intelligence in Healthcare Market: Growth and Forecast
7.8.1 By Value (2014-2018)
7.8.2 By Value (2019-2024)
7.8.3 By Component, By Value (2014-2018)
7.8.4 By Component, By Value (2019-2024)
7.8.5 By Technology, By Value (2014-2018)
7.8.6 By Technology, By Value (2019-2024)

8. Global Artificial Intelligence in Healthcare Market Dynamics
8.1 Global Artificial Intelligence in Healthcare Market Drivers
8.2 Global Artificial Intelligence in Healthcare Market Restraints

9. Global Artificial Intelligence in Healthcare Market Trends

10. Porter Five Force Analysis

11. SWOT Analysis

12. Competitive Landscape: Recent Developments, Artificial Intelligence in Healthcare Market

13. Policy and Regulatory Landscape

14. Company Profiles
14.1 IBM Watson Health
14.2 Stryker Corporation
14.3 General Vision, Inc.
14.4 NVIDIA Corporation
14.5 CloudMedx Inc.
14.6 DEEP Genomics
14.7 Next IT Corp.
14.8 Microsoft Corporation
14.9 General Electric
14.10 Google

List of Figures
Figure 1: Artificial Intelligence in Healthcare Market Segmentation Flowchart
Figure 2: Global Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
Figure 3: Global Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
Figure 4: Projected global population (In Billions)
Figure 5: Projected global population aged 60 years & above (In Billions)
Figure 6: Distributions of persons aged 60 years or above by region in millions, 2015 and 2030F
Figure 7: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
Figure 8: Expected Global Medical Spending in 2020, By Region, (% of Total)
Figure 9: Regional Expected Healthcare Industry Growth Rate, By Year 2020
Figure 10: Top artificial intelligence applications and their estimated potential annual benefits, By 2026
Figure 11: Global Prevalence of Different Type of Cancer, 2017 (In Thousands)
Figure 12: Global Prevalence of Prostate Cancer (2014-2018, Thousands)
Figure 13: Oncologists per 1 Million of Population, By Select Country, 2018
Figure 14: Global AI Hardware in Healthcare Market, By Value, 2014-2018 (USD Billion)
Figure 15: Global AI Hardware in Healthcare Market, By Value, Forecast, 2019-2024 (USD Billion)
Figure 16: lobal AI Software in Healthcare Market, By Value, 2014-2018 (USD Billion)
Figure 17: Global AI Software in Healthcare Market, By Value, Forecast, 2019-2024 (USD Billion)
Figure 18: Global AI Services in Healthcare Market, By Value, 2014-2018 (USD Billion)
Figure 19: Global AI Services in Healthcare Market, By Value, Forecast, 2019-2024 (USD Billion)
Figure 20: Global Natural Language Processing in Healthcare Market, By Value, 2014-2018 (USD Billion)
Figure 21: Global Natural Language Processing in Healthcare Market, By Value, Forecast, 2019-2024 (USD Billion)
Figure 22: Global Machine Learning in Healthcare Market, By Value, 2014-2018 (USD Billion)
Figure 23: Global Machine Learning in Healthcare Market, By Value, Forecast, 2019-2024 (USD Billion)
Figure 24: Other Global AI Technologies in Healthcare Market, By Value, 2014-2018 (USD Billion)
Figure 25: Other Global AI Technologies in Healthcare Market, By Value, Forecast, 2019-2024 (USD Billion)
Figure 26: Global Healthcare Providers in AI Market, By Value, 2014-2018 (USD Billion)
Figure 27: Global Healthcare Providers in AI Market, By Value, Forecast, 2019-2024 (USD Billion)
Figure 28: Global Pharmaceutical Organizations in AI Market, By Value, 2014-2018 (USD Billion)
Figure 29: Global Pharmaceutical Organizations in AI Market, By Value, Forecast, 2019-2024 (USD Billion)
Figure 30: Other Global End Users in AI Healthcare Market, By Value, 2014-2018 (USD Billion)
Figure 31: Other Global End Users in AI Healthcare Market, By Value, Forecast, 2019-2024 (USD Billion)
Figure 32: Global Healthcare Landscape, By Select Region
Figure 33: Global Artificial Intelligence in Healthcare Market Size, By Region, 2018 (%)
Figure 34: Global Artificial Intelligence in Healthcare Market Size, By Region, 2024F (%)
Figure 35: North America Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
Figure 36: North America Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
Figure 37: North America GDP, 2012-2017 (USD Trillion)
Figure 38: North America GDP per capita, current prices, 2013-2023F (In USD)
Figure 39: Prevalence of Different Type of Cancer in North America in year 2016 & 2017 ( In Hundreds)
Figure 40: North America, Cancer Incidence (In Millions)
Figure 41: North America, Cancer Incidence, By Technology, 2019E (In %)
Figure 42: North America Population above 65 year, 2015, 2030F, & 2050F (In Millions)
Figure 43: Most frequent neurological diseases reported in primary care, In North America, 2017 (%)
Figure 44: Total Number of People With Cardiovascular Disorders in North America, By Type, 2017 (In thousands)
Figure 45: North America Artificial Intelligence in Healthcare Market: By Component, By Value, 2014-2018 (USD Billion)
Figure 46: North America Artificial Intelligence in Healthcare Market: By Component, By Value, 2019E-2024F (USD Billion)
Figure 47: North America Artificial Intelligence in Healthcare Market: By End User, By Value, 2014-2018 (USD Billion)
Figure 48: North America Artificial Intelligence in Healthcare Market: By End User, By Value, 2019E-2024F (USD Billion)
Figure 49: U.S. Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
Figure 50: U.S. Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
Figure 51: U.S Artificial Intelligence Market, Recent Government Initiatives
Figure 52: Leading Sites of New Cancer Cases in the United States amongst Males, 2018 (In %)
Figure 53: Leading Sites of New Cancer Cases in the United States amongst Females, 2018 (In %)
Figure 54: Estimated New Cases of Cancer in the United States, By Type 2018 (In %)
Figure 55: Estimated New Cases of Cancer in the United States, 2014-2018 (In Thousands)
Figure 56: United States, Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 57: Total Number of People With Cardiovascular Disorders in United States, By Type, 2017 (In thousands)
Figure 58: Estimated New Cases of Cancer in the United States, By State, 2018
Figure 59: Estimated Numbers of US Cancer Survivors (As of January 1, 2016)
Figure 60: Estimated Numbers of US Cancer Survivors (As of January 1, 2026F)
Figure 61: Most costly neurological disorders in United States, In 2017
Figure 62: U.S., Per Capita Expenditure on Healthcare, 2012-2018 (In USD)
Figure 63: Proportion of people with Alzheimer disease, In United States, In 2017
Figure 64: Projected number of people with Alzheimer disease aged 65 and older, In United States, In million, In 2017
Figure 65: Aggregate cost of care for Alzheimer, By payer, In United States, In 2017
Figure 66: Canada Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
Figure 67: Canada Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
Figure 68: Prevalence of Different Type of Cancer in Canada, 2016 & 2017 ( In Hundreds)
Figure 69: Cancer Fact Sheet of Canada, 2017
Figure 70: Canada Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 71: Total Number of People With Cardiovascular Disorders in Canada, By Type,2017 (In thousands)
Figure 72: Canada, Expenditure on Health as a share of GDP, 2012-2017 (In %)
Figure 73: Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD)
Figure 74: North America Artificial Intelligence in Healthcare Market, Country Share, 2014-2018 (% of Total)
Figure 75: North America Artificial Intelligence in Healthcare Market, Country Share, 2018F-2023F (% of Total)
Figure 76: Europe Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
Figure 77: Europe Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
Figure 78: Europe, Cancer Incidence, 2019E-2035F (In Millions)
Figure 79: Europe, Cancer Incidence, By Type, 2019E
Figure 80: Prevalence of Different Type of Cancer in Western Europe in year 2016 & 2017 ( In Thousands)
Figure 81: Europe, Per Capita Health Expenditure, By Select Country, 2017 (USD)
Figure 82: Breakdown of Total Health Expenditure in Europe, 2018 (%)
Figure 83: GDP, Europe Region, By Select Country, 2017 (In Trillion USD)
Figure 84: Europe Artificial Intelligence Market, Recent Government Initiatives
Figure 85: Western Europe Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 86: Total Number of People With Cardiovascular Disorders in Western Europe, By Type, 2017 (In thousands)
Figure 87: Europe Artificial Intelligence in Healthcare Market: By Component, By Value, 2014-2018 (USD Billion)
Figure 88: Europe Artificial Intelligence in Healthcare Market: By Component, By Value, 2019E-2024F (USD Billion)
Figure 89: Europe Artificial Intelligence in Healthcare Market: By End User, By Value, 2014-2018 (USD Billion)
Figure 90: Europe Artificial Intelligence in Healthcare Market: By End User, By Value, 2019E-2024F (USD Billion)
Figure 91: Germany Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
Figure 92: Germany Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
Figure 93: Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 94: Germany, Population ages 65 and above, 2012-2017 (% total)
Figure 95: Germany, Spending on Healthcare, 2015 & 2040E, (USD Per Person)
Figure 96: Germany, Healthcare Related Statistics, 2017
Figure 97: Prevalence of Different Type of Cancer in Germany in year 2016 & 2017 ( In Hundreds)
Figure 98: Germany Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 99: Total Number of People With Cardiovascular Disorders in Germany, By Type, 2017 (In thousands)
Figure 100: U.K. Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
Figure 101: U.K. Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
Figure 102: Cancer Statistics in the United Kingdom
Figure 103: U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 104: U.K Artificial Intelligence Market, Some of the Recent Government Initiatives
Figure 105: UK, Healthcare Infrastructure Related Statistics
Figure 106: U.K, Population Ages 65 and Above, (% of total), 2012-2017
Figure 107: Proportion of people with symptoms of mental disorders in United Kingdom
Figure 108: Europe Artificial Intelligence in Healthcare Market, Country Share, Historic, 2014-2018(% of Total)
Figure 109: Europe Artificial Intelligence in Healthcare Market, Country Share, Forecast, 2019-2024 (% of Total)
Figure 110: APAC Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
Figure 111: APAC Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
Figure 112: Estimated number of deaths from prostate cancer in 2012 and 2030
Figure 113: World health expenditure as % of GDP
Figure 114: Population ages 65 and above, APAC Region, By Select Countries, 2017 (% of total)
Figure 115: Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total)
Figure 116: APAC, GDP, By Select Country, 2017 (In USD Trillion)
Figure 117: Most frequent neurological diseases reported in primary care, In Asia Pacific, 2017
Figure 118: APAC Artificial Intelligence in Healthcare Market: By Component, By Value, 2014-2018 (USD Billion)
Figure 119: APAC Artificial Intelligence in Healthcare Market: By Component, By Value, 2019E-2024F (USD Billion)
Figure 120: APAC Artificial Intelligence in Healthcare Market: By End User, By Value, 2014-2018 (USD Billion)
Figure 121: APAC Artificial Intelligence in Healthcare Market: By End User, By Value, 2019E-2024F (USD Billion)
Figure 122: India Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
Figure 123: India Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
Figure 124: Key factors affecting the Indian Healthcare Industry
Figure 125: India, Total Population, 2013-2023F (In Billion)
Figure 126: India, Share of Urban Population, 2012-2017 (In %)
Figure 127: India, GDP Growth Per Year, 2015-2019 (In %)
Figure 128: India, Total deaths due to cancer, 2018
Figure 129: Top 5 forms of cancer in men and women in India
Figure 130: China Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
Figure 131: China Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
Figure 132: China, GDP Growth Per Year, 2015-2019 (In %)
Figure 133: China, Share of Urban Population, 2012-2017 (In %)
Figure 134: China, Total Population, 2013-2021F (In Billion)
Figure 135: Prevalence of Different Type of Cancer in China in year 2016 & 2017 ( In Hundreds)
Figure 136: Number of new cases, Males (all ages), 2018 (In %)
Figure 137: Number of new cases, Females (all ages), 2018 (In %)
Figure 138: China, Cancer Mortality Rate, By Cancer Site, 2018
Figure 139: China Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 140: Total Number of People With Cardiovascular Disorders in China, By Type,2017 (In thousands)
Figure 141: China Artificial Intelligence Market, Recent Government Initiatives
Figure 142: APAC Artificial Intelligence in Healthcare Market, Country Share, Historic, 2014-2018 (% of Total)
Figure 143: APAC Artificial Intelligence in Healthcare Market, Country Share, Forecast, 2019-2024 (% of Total)
Figure 144: ROW Artificial Intelligence in Healthcare Market Size, By Value, 2014-2018 (USD Billion)
Figure 145: ROW Artificial Intelligence in Healthcare Market Size, By Value, Forecast, 2019-2024 (USD Billion)
Figure 146: Middle East and North Africa, GDP, 2012-2017 (In USD Trillion)
Figure 147: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %)
Figure 148: Prevalence of Different Type of Cancer in Middle East and North Africa in year 2016 & 2017 ( In Hundreds)
Figure 149: Prevalence of Different Type of Cancer in Brazil in year 2016 & 2017 ( In Hundreds)
Figure 150: ROW Artificial Intelligence in Healthcare Market: By Component, By Value, 2014-2018 (USD Billion)
Figure 151: ROW Artificial Intelligence in Healthcare Market: By Component, By Value, 2019E-2024F (USD Billion)
Figure 152: ROW Artificial Intelligence in Healthcare Market: By End User, By Value, 2014-2018 (USD Billion)
Figure 153: ROW Artificial Intelligence in Healthcare Market: By End User, By Value, 2019E-2024F (USD Billion)
Figure 154: Recent Developments, Artificial Intelligence in Healthcare Market
Figure 155: Recent Developments, Artificial Intelligence in Healthcare Market
Figure 156: Stryker Corporation, Revenue, 2013-2017 (In USD Million)
Figure 157: Stryker Corporation, Revenue, By Business Segment, 2017 (In %)
Figure 158: Stryker Corporation, Net Sales, By Geographic Region, 2017 (In %)
Figure 159: NVIDIA Corporation, Revenue, 2014-2018 (In USD Million)
Figure 160: NVIDIA Corporation, Revenue, By Business Segment, 2018 (In %)
Figure 161: NVIDIA Corporation, Net Sales, By Geographic Region, 2018 (In %)
Figure 162: NVIDIA Corporation, Revenue, By Specialized Market, 2018 (In %)
Figure 163: Microsoft Corporation, Revenue, 2014-2018 (In USD Million)
Figure 164: Microsoft Corporation, Revenue, By Business Segment, 2018 (In %)
Figure 165: Microsoft Corporation, Net Sales, By Geographic Region, 2018 (In %)
Figure 166: General Electric, Revenue, 2014-2018 (In USD Billion)
Figure 167: General Electric, Revenue, By Business Segment, 2018 (In %)
Figure 168: General Electric, Healthcare Segment, Net Sales, By Geographic Region, 2018 (In %)
Figure 169: General Electric, Healthcare Sub-Segment Revenue, 2018 (In %)

List of Tables
Table A: Recent Company Acquisitions and Mergers in Artificial Intelligence in Healthcare Market
Table B: Germany, Healthcare Related Statistics, 2017
Table C: Estimated number of people living with cancer, 2020F and 2030F
Table D: Global Access to Healthcare Index, Ranking of Select Countries in Asia Pacific Region, 2017 (score out of 10)
Table F: India, Cancer Statistics

発刊日

2019/04/30

体裁

PDF / 215ページ

販売価格

2,400USD

発行

Azoth Analytics

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

医療IT

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE